Oxford Global, Manchester Central Convention Complex
27/02/23
Biomarkers 2023, designed to provide forward-looking insights into the latest trends and tools impacting biomarker research, it brings together leading experts from global pharmaceutical organisations, innovative biotech companies and internationally renowned academic institutions, working across multiple therapeutic areas and states of drug development. It includes over 90 cutting-edge presentations and discussion sessions, 8+ hours of valuable networking sessions and an exhibition hall showcasting 50+ vendor companies. Panel Discussions Day One: Track 1: Scientific and Regulatory Considerations for the Qualification of Biomarkers Track 2: Reflection when Biomarker Development Fails and Lessons Learnt Track 3: Clinical Diagnostics and Clinical Biomarkers Track 4: AI and Digital Pathology in Clinical Practice Panel Discussions Day Two: Track 1: Biomarker Strategies in Neurodegenerative Therapeutics Track 2: Implementing Patient-Centric Biomarkers in Clinical Trials Track 3: Efficacy and Pharmacokinetic Endpoints: Gene Therapy Translation from Preclinical to Clinical Track 4: Applying Single Cell and Omic Technologies in Drug Discovery and Development
|